Standout Papers

Memantine in Moderate-to-Severe Alzheimer's Disease 2003 2026 2010 2018 1.5k
  1. Memantine in Moderate-to-Severe Alzheimer's Disease (2003)
    ‌Barry Reisberg, Rachelle S. Doody et al. New England Journal of Medicine
  2. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse (2007)
    Chris G. Parsons, Albrecht Stöffler et al. Neuropharmacology

Immediate Impact

6 by Nobel laureates 27 from Science/Nature 84 standout
Sub-graph 1 of 20

Citing Papers

General access to cubanes as benzene bioisosteres
2023 StandoutNature
Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
5 intermediate papers

Works of Albrecht Stöffler being referenced

Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
2000
and 1 more

Author Peers

Author Last Decade Papers Cites
Albrecht Stöffler 874 959 300 1038 954 18 3.2k
Hans Jörg Möbius 604 899 200 910 847 22 2.6k
G K Wilcock 564 733 155 1303 1430 22 3.5k
Michelle Gee 497 1237 242 1596 522 24 3.4k
Ara S. Khachaturian 365 1347 196 1704 813 47 4.1k
Kimberly Schafer 352 1488 417 1843 934 38 4.6k
Marwan Sabbagh 283 1073 287 1771 506 14 3.4k
Kate Zhong 552 1376 232 2542 1338 34 5.2k
Shelia Jin 205 1230 164 1450 885 27 3.8k
Lutz Froelich 347 1273 350 1735 535 51 3.6k
Lawrence Friedhoff 286 1529 186 1108 1477 54 3.8k

All Works

Loading papers...

Rankless by CCL
2026